Real World Evidence (RWE) to Enhance Value-Based Market Access of the PCSK9 Inihibitors in Italy- Treatment Patterns and Cv-Related Hospitalizations Among High Risk Hefh and Secondary Prevention Patients in Three Real-World Data Systems
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1821
https://www.valueinhealthjournal.com/article/S1098-3015(16)33187-4/fulltext
Title :
Real World Evidence (RWE) to Enhance Value-Based Market Access of the PCSK9 Inihibitors in Italy- Treatment Patterns and Cv-Related Hospitalizations Among High Risk Hefh and Secondary Prevention Patients in Three Real-World Data Systems
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33187-4&doi=10.1016/j.jval.2016.09.1821
First page :
A663
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1720